0 Комментарии
0 Поделились
894 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
CD47 Targeting Therapeutics Market Growth Supported by Expanding Immunotherapy ResearchThe CD47 Targeting Therapeutics Market Growth is strongly supported by the expanding field of cancer immunotherapy. Over the past decade, immunotherapy has transformed oncology treatment by enabling the immune system to identify and attack cancer cells more effectively. CD47-targeting therapies represent a new generation of immunotherapies that aim to overcome one of the major mechanisms used...0 Комментарии 0 Поделились 135 Просмотры 0 предпросмотр
-
The 2026 CD47 Targeting Therapeutics Market: Pioneering the "Don’t Eat Me" Signal Suppression EraIn the sophisticated landscape of 2026, oncology has moved beyond simple cell destruction to a strategic mastery of the immune system. The CD47 Targeting Therapeutics Market represents the cutting edge of this shift, focusing on a transmembrane protein that acts as a "don’t eat me" signal for cancer cells. By blocking this checkpoint, these next-generation therapies enable...0 Комментарии 0 Поделились 323 Просмотры 0 предпросмотр